Benjamin Franklin's aphorism — an ounce of prevention is worth a pound of cure — is quoted at every public health conference and ignored in nearly every healthcare payment system. We know prevention saves money. We know it saves suffering. Yet our insurance architecture, our billing codes, and our cultural expectations all reward treatment and penalize the daily habits that keep people well. Health Savings Accounts offer a structural fix, but only if we understand what went wrong in the first place.
How Insurance Lost Its Way
Health insurance began as catastrophe coverage — a rational hedge against ruinous medical bills from accidents, surgery, or serious illness. You paid premiums for decades hoping never to use the policy, just as you insure your house against fire. The model worked because the insured understood they were protecting against rare, high-cost events.
Over the twentieth century, insurance morphed into a payment system for everything. Routine office visits, prescriptions, preventive screenings, mental health counseling, physical therapy — all routed through third-party payers who negotiated rates, processed claims, and inserted themselves between patient and provider. The consumer stopped being a consumer. When someone else pays the bill, price sensitivity disappears. When price sensitivity disappears, costs explode.
The result is a healthcare economy where nobody knows what anything costs, nobody asks, and nobody cares until premiums rise again. A patient with full coverage will accept a $400 brand-name drug when a $15 generic works identically, because their copay is the same. A parent will visit urgent care for a viral cold because insurance covers it, while skipping a five-dollar xylitol nasal spray that might prevent the ear infection that leads to a $2,000 specialist visit. The incentives are perfectly designed to produce the most expensive outcome.
The Lost Art of Consumer Responsibility
Consumer responsibility is not a libertarian slogan. It is an economic necessity. Every other sector of the economy — housing, food, transportation, education — functions because buyers compare value and make tradeoffs. Healthcare is the exception, and the exception is bankrupting us.
Americans spend nearly twice as much per capita on healthcare as any other developed nation, yet our outcomes on measures like infant mortality, life expectancy, and chronic disease burden lag behind countries that spend far less. The difference is not technology — American hospitals have the best equipment in the world. The difference is how we allocate resources. We spend lavishly on treatment and miserly on prevention. We fund end-stage renal disease dialysis while underfunding the diabetes prevention that might have avoided kidney failure in the first place.
Restoring consumer responsibility does not mean abandoning the sick or punishing the poor. It means creating a system where individuals have a direct financial stake in daily health decisions — and where the cheapest, most effective option is also the most rational choice.
Health Savings Accounts: Putting Control Back
Health Savings Accounts (HSAs) pair a high-deductible health plan with a tax-advantaged savings account that the individual owns and controls. Unspent funds roll over year to year and accumulate. The logic is straightforward: you pay routine expenses from your own HSA, which makes you price-conscious. Insurance covers catastrophes, which is what insurance is for.
When patients control their healthcare dollars, behavior changes. They ask what things cost. They compare alternatives. They invest in prevention because every dollar spent preventing illness is a dollar that stays in their account. A parent who pays for a child's xylitol nasal spray from an HSA — at roughly five dollars a month — is making a rational economic decision when the alternative is repeated copays for antibiotics, specialist visits, and possibly ear tube surgery.
HSAs also create the transparency our system desperately lacks. When you spend your own money, you demand to know the price before you buy. This pressure, applied across millions of consumers, would do more to control healthcare costs than any regulatory scheme Congress has devised.
The Singapore Model
Singapore offers a proof of concept. The city-state's healthcare system uses a unified fund model — Medisave — where every working citizen contributes a portion of income to a personal health account. Medisave pays for routine care. Catastrophic insurance covers major events. Government subsidies protect the indigent. The result: Singapore spends roughly 4% of GDP on healthcare (compared to America's 18%) while achieving superior outcomes on infant mortality, life expectancy, and access to care.
The key insight from Singapore is not any single policy but the architecture: individual accounts create ownership, ownership creates responsibility, and responsibility creates the incentive structure that makes prevention rational. Singaporeans don't skip preventive care because they understand it protects their own money. Americans skip prevention because their insurance company pays for treatment but not for the daily habits that prevent the need for treatment.
Prevention in Practice: Pennies vs. Dollars
Defense medicine makes the economic case for prevention concrete. Consider upper respiratory health — one of the most common reasons Americans visit physicians, miss work, and consume antibiotics.
A child with recurrent otitis media might accumulate costs over a single winter that include multiple office visits ($150–$300 each with copays), antibiotic prescriptions ($10–$50 each), and potentially a referral to an ENT specialist ($250–$500) followed by bilateral myringotomy with tube placement ($3,000–$5,000). Total cost: easily $5,000 or more, borne by the family in copays and deductibles and by the system in covered expenses.
The preventive alternative — xylitol nasal spray used twice daily — costs approximately five dollars per month. Over the same winter, that is fifteen dollars. The mechanism is adherence blockade, not antibiotic killing, as I describe in Killing Germs Doesn't Work; Let's Try Feeding Them. In my clinical practice, this approach prevented more than 90% of recurrent infections. The math is not close. Prevention is not merely better medicine. It is dramatically cheaper medicine.
The same arithmetic applies across defense medicine:
- Nasal hygiene vs. sinus surgery and chronic antibiotic courses
- Xylitol gum vs. dental fillings, root canals, and crowns
- Airway defense support vs. asthma controller medications and ER visits
- Daily preventive habits vs. the cascade of specialist referrals that follows neglected primary care
In every case, the preventive intervention costs pennies to dollars. The treatment cascade costs dollars to tens of thousands. An HSA makes this math visible to the person making the decision.
Public Health Transparency
A reformed healthcare economy requires more than individual accounts. It requires transparency — public reporting of costs, outcomes, and the evidence behind preventive interventions. Patients cannot make rational choices in an opaque market.
When Finland published the results of xylitol gum studies showing 40–50% reduction in dental caries, parents and dentists could act on the evidence. When our clinical data showed 90%+ reduction in recurrent otitis with nasal xylitol, the information struggled to reach a system incentivized to treat ears, not prevent infections. Public health transparency means making cost and outcome data accessible, comparable, and honest — so that prevention competes fairly with treatment in the marketplace of ideas and dollars.
Common Sense Medicine was founded as a 501(c)(3) precisely to fill this gap: to fund and publish the research that makes preventive, defense-oriented care visible and credible. When patients and policymakers can see that a five-dollar nasal spray prevents a five-thousand-dollar surgery, the economic argument for HSAs and prevention becomes unanswerable.
Aligning Incentives with Health
The paradigm shift to defense medicine requires more than clinical insight. It requires an economic structure that rewards keeping people well instead of profiting from their illness. HSAs are one piece of that structure. Transparency is another. The cultural shift — teaching patients that daily prevention is their responsibility and their best investment — is the third.
An ounce of prevention is worth a pound of cure. We have known this for centuries. Health Savings Accounts, combined with the practical tools of defense medicine, finally give us a payment system that acts as if it were true. The question is whether we have the collective will to choose the five-dollar solution before we need the five-thousand-dollar one.
For the philosophical foundation of this approach, see Seeing with New Eyes: The Paradigm Shift to Defense Medicine.